Aim: Helicobacter pylori (HP) has been implicated as a risk factor for cardiovascular and atherosclerotic diseases. Arterial stiffness determined by pulse wave velocity (PWV) or the cardio-ankle vascular index (CAVI) has been shown to be higher in HP-positive subjects than in HP-negative subjects; however, this result has been observed only in young subjects. The aim of the study was to investigate the possible correlation between HP infection and PWV or CAVI in middle-aged subjects. 
ously investigated 1, 2) . Although various case-control studies have shown a positive relationship between HP infection and myocardial infarction 1) or ischemic heart disease 3) , conflicting results have also been reported 4, 5) . Some reports have shown a positive relation between HP infection and coronary heart disease [6] [7] [8] , while others have found no such relationship 2, [9] [10] [11] . In regards to the relation between HP infection and stroke, positive 12) and negative 13) test results have been reported. It has also been reported that the eradication of HP and antibiotics against HP reduced the recurrence rate of acute coronary events 14, 15) . Arterial stiffness is an independent and impor-
Introduction
Helicobacter pylori (HP) is involved in the pathogenesis of several gastrointestinal diseases. Recently, HP has also been implicated in the pathogenesis of extra-gastric diseases, among which cardiovascular disease and atherosclerotic diseases are the most rigor-tant predictor of cardiovascular mortality, coronary events and several atherosclerotic diseases 16) . Arterial stiffness can be evaluated by measuring brachial-ankle pulse wave velocity (baPWV) and the cardio-ankle vascular index (CAVI) 17) . While both parameters are calculated from the pulse transit time and distance traveled by pulse between two recording sites, CAVI has been shown to be less dependent on blood pressure than baPWV 18) . It has been shown that the arterial stiffness determined by baPWV was higher in HP-positive subjects than in HP-negative subjects, even though such a result has been observed only in young subjects [19] [20] [21] . Pepsinogens (PGs) are precursors of pepsin and consist of two isozymes, PG and PG . It has been shown previously that decreases in serum PG level and the ratio of PG and PG indicate atrophic gastritis (AG) 22) . In this study, we investigated the HP status, PGs, baPWV, CAVI and metabolic markers in order to examine whether the HP status and AG contribute to the degree of arterial stiffness in aged individuals.
Subject and Methods

Study Population
In 2005, 393 individuals, all either 60 or 65 years old, were invited to undergo health checkups and agreed to participate in the present study. All subjects were healthy and resided in a city (Yukuhashi) and 5 towns (Saigawa, Toyotsu, Tsuiki, Katsuyama, and Kouge) in Fukuoka Prefecture, Japan. The study areas were randomly selected from urban, suburban, and rural communities to achieve a balance of living environments, including sociodemographic backgrounds, dietary habits, health behavior status, and medical treatment. The study complied with the ethics rules for human experimentation stated in the Declaration of Helsinki, and was approved by the Human Investigations Committee of Kyushu Dental College. Informed consent was obtained from all patients.
Exclusion Criteria
Exclusion criteria were a history of gastrectomy (n 13), a history of HP eradication treatment (n 22), ankle-brachial pressure index (ABI) less than 0.9 (n 7), blood samples not taken (n 5), and baPWV, CAVI and ABI not measured (n 8); therefore, 343 individuals (147 males and 196 females) were analyzed.
Data Collection
baPWV, CAVI, and ABI were measured using VaSera VS-1000 (Fukuda Denshi, Tokyo, Japan). We calculated the mean bilateral brachial-ankle PWVs as baPWV. We also used the mean of right and left CAVI as CAVI. Serum pepsinogen concentrations were measured out by chemiluminescent enzyme immunoassay (PG / Lumipulse; Fujirebio Inc., Tokyo, Japan). Atrophic gastritis (AG) was diagnosed based on previously described criteria (PG ≤ 70 ng/mL and PG / ratio ≤ 3.0) 22) . The serum immunoglobulin G (IgG) antibody to HP was measured by enzyme linked immunosorbent assay (ELISA) (Eiken, Tokyo, Japan). IgG to HP 10 U/mL was considered negative, and ≥ 10 U/mL as positive. Serum adiponectin and ghrelin levels were measured by ELISA kits (by Fujirebio Inc., Tokyo, Japan for adiponectin and by Mitsubishi Kagaku Iatron Inc., Tokyo, Japan for ghrelin). Leptin was measured by radioimmunoassay (Human leptin RIA kit; Linco, St Charles, MO, USA). The serum triglycerides (TG), high-density lipoprotein cholesterol (HDL-cholesterol), low-density lipoprotein cholesterol (LDL-cholesterol) and blood sugar were measured by enzymatic methods. Insulin was measured by a chemiluminescent enzyme immunoassay. Hemoglobin A1c (HbA1c) and C-reactive protein (CRP) were measured by latex agglutination methods. Body mass index (BMI) was calculated from height and weight (BMI weight (Kg)/height 2 (M)). Drinking and smoking habits, and the history of HP eradication therapy and gastrectomy were obtained by questionnaires.
Statistical Analysis
All data are reported as the means standard deviation. Differences in mean values between groups were assessed by Student's t -test, Mann-Whitney's U-test, and the 2 -test. PWV and CAVI were adjusted for age, gender, smoking, drinking, heart, systolic blood pressure, BMI, HDL-cholesterol, LDL-cholesterol, TG, BS, and insulin using analysis of covariance with Bonferroni's adjustments for multiple comparisons, and shown as PWVc and CAVIc. The correlation between the PG / ratio and CAVIc or PWVc was measured with Spearman's rank correlation test. All statistical analyses were performed using SPSS 15.0J for Windows (SPSS Inc., Tokyo, Japan).
Results
The subjects were divided according to PGs (Table 1) or HP-IgG ( Table 2) . When the subjects were divided into two groups according to serum PG, the number of atrophic gastritis (AG)-positive was 122 and AG-negative was 221, as shown in Table 1 . BMI was lower in the AG-positive group than in the AG-negative group, while other factors, such as gender, age, smoking, drinking, systolic blood pressure (SBP), and heart rate were not significantly different. As shown in Fig. 1 , a statistically significant correlation was found between PG / and CAVIc (r 0.131, p 0.015), and between PG / and PWVc (r 0.114, p 0.034). When the subjects were divided into two groups according to positive and negative HP-IgG, the number of HP-IgG-positive was 210 and HP-IgGnegative was 133. BMI was lower in the HP-IgGpositive group than in the HP-IgG-negative group ( Table 2) .
Arterial stiff parameters of AG-positive and AGnegative are shown in Table 3 . PWV and CAVI were significantly higher in the AG-positive group than in the AG-negative group. Even when PWV and CAVI were adjusted for gender, age, smoking, drinking, heart, systolic blood pressure, BMI, blood sugar, insulin and lipids using the covariance method, both PWVc and CAVIc were also significantly higher in the AG-positive group than in the AG-negative group ( Table 3) . These data indicated that arterial stiffness was more advanced in AG-positive subjects than in the AG-negative group.
When the subjects were divided into two groups according to HP status, PWV and CAVI values tended to be higher in the HP-IgG-positive group than in the HP-IgG-negative group, although the difference did not reach statistical significance ( Table 4) . Differences in PWVc and CAVIc between groups also showed similar trends without statistical significance ( Table 4) . These data indicated that arterial stiffness was only slightly increased in HP-positive subjects than in HPnegative subjects.
Metabolic parameters were compared between AG-positive and AG-negative groups to investigate the mechanism by which AG was related to arterial stiffness ( Table 5) . HDL-cholesterol, adiponectin, and CAVIc was CAVI adjusted for age, gender, smoking, drinking, heart, systolic blood pressure, BMI, HDL-cholesterol, LDL-cholesterol, TG, BS, and insulin using analysis of covariance with Bonferroni's adjustments for multiple comparisons. ghrelin levels were significantly lower in the AG-positive group than in the AG-negative group even after adjusting for age, gender and BMI; however, there were no differences in C-reactive protein or the white blood cell count between AG-positive and -negative groups ( Table 5) .
Discussion
We demonstrated in the present investigation that arterial stiffness, determined by baPWV and CAVI, was different between elderly with AG and those without AG, while it was unrelated to HP status. Most cases of HP infection develop to acute gastritis, which then progresses to chronic gastritis, intestinal metaplasia, and occasionally gastric cancer, in a sequence known as the Correa pathway. Because positive HP-IgG was representative of preceding HP infection and, possibly, mild gastritis, and since subjects with negative HP-IgG presumably included those with advanced intestinal metaplasia 23) , PG was more sensitive to diagnose AG than HP-IgG in our subjects.
Previous reports stated that arterial stiffness evaluated by baPWV differed according to HP status in the young, but not in the elderly [19] [20] [21] . Adachi et al. reported that in subjects under 39 years of age, baPWV was higher in the HP-positive group than in HP-negative subjects; however, the same group of investigators failed to show such a difference in subjects over 40 years of age. Saijo et al. reported that a positive relation of HP and arterial stiffness was observed in male subjects under 50 years of age. Yoshi- Table 5 . Comparison of metabolic parameters and inflammatory parameters between AG-positive and -negative subjects after adjusting for age, gender and body mass index AG-positive (n 122) kawa et al. reported that HP-positive young subjects (30 − 49 years old) with impaired glucose metabolism were related to an increase in baPWV, but this was not the case in the elderly (50 − 69 years old). In our study, arterial stiffness evaluated by baPWV and CAVI was not different according to HP status, because our subjects were 60 or 65 years old; however, these parameters were significantly different when subjects were divided by pepsinogen values. Furthermore, we showed a significant correlation between the PG / ratio and CAVI. These results indicate a possible correlation between AG and arterial stiffness. Moreover, arterial stiffness advanced in accordance with the severity of AG. This correlation between AG and arterial stiffness has been reported in a previous study, in which carotid intima-media thickness was greater in subjects with atrophic gastritis 24) ; however, no report has shown the relation of AG and arterial stiffness evaluated by baPWV or CAVI.
The mechanism by which AG accelerated atherosclerosis was not clear. In metabolic risk factors for atherosclerosis, HDL-cholesterol was decreased and TG was slightly increased, although BMI was lower 25) in AG subjects in our study. These results were consistent with previous reports 26, 27) . It has been shown that HDL-cholesterol was significantly decreased in HP-positive elderly subjects 28, 29) . HDL-cholesterol has been shown to increase after successful eradication of HP 26, 27) . It has also been reported that HP affects other lipid profiles, such as total cholesterol 30) , LDL, and lipoprotein-a 28) ; however, total cholesterol and LDL-cholesterol were not different according to AG or HP status. In our study, the adiponectin level was lower in the AG-positive group than in the AG-negative group. Although the mechanism of the phenomenon remains to be elucidated, the adiponectin level has been reported to decrease in patients with cardiovascular disease and atherosclerotic diseases [31] [32] [33] . Interestingly, the ghrelin level was significantly lower in the AG-positive group than the AG-negative group, which has also been shown in several studies 34, 35) . In addition, it has been reported that ghrelin was protective against cardiovascular damages in humans 36, 37) , although its critical role remains to be investigated 38) ; therefore, the reduced adiponectin and ghrelin seem to have been related to increased arterial stiffness in our AG-positive group.
Other factors, such as insulin and blood sugar, were not different between AG-positive and AG-negative groups. It has been reported that increases in inflammatory factors, such as CRP, WBC and fibrinogen as a consequence of HP infection, are candidates to explain the progression of arterial stiffness 29, 39) . In our study, however, neither CRP nor WBC was different between AG-positive and AG-negative groups. Nevertheless, mucosal inflammation of the stomach may have influenced arterial stiffness in our subjects, because PG has been regarded as a marker of inflammation of the gastric mucosa as well as gastric atrophy 40) , Other pro-inflammatory cytokines, such as tumor necrosis factor and IL-6, which are closely associated with both HP infection 41) and atherosclerosis 42) , are also candidates, which may explain our findings. It thus seems likely that AG caused by HP, but not HP per se, is one of the risk factors for atherosclerosis; however, the difference in metabolic parameters does not seem to explain completely the difference in arterial stiffness between AG-positive and AG-negative groups. Further investigations are needed to clarify the mechanisms by which AG promotes arterial stiffness.
There are several limitations of this study. First, we could not show direct evidence of an interaction between AG and arterial stiffness because this study was not prospective. A prospective, interventional study with eradication of HP seems to be necessary to clarify the direct effect of AG on the development of atherosclerosis. Second, the small number of subjects in our study lessened the statistical power. Third, HP infection and AG were determined by serological methods alone. For more accurate diagnosis, HP status and AG should be determined by endoscopy and biopsy. Fourth, we did not measure lipoprotein-a 28) , vitamin B12 24) , fibrinogen, and cytokine levels 27) , all of which have been reported to be related to arterial stiffness.
In conclusion, our investigation revealed that HP affects arterial stiffness via atrophic gastritis in the elderly. It thus seems necessary to investigate whether atrophic gastritis is a direct risk factor for arterial stiffness or whether other metabolites, such as HDL-cholesterol, adiponectin, and ghrelin, are involved in the sequence.
